WHA approves resolution on IGWG

According to Thiru Balasubramaniam, the WHA has now adopted a resolution on the WHO’s Intergovernmental Working Group (IGWG) on Public Health, Innovation and Intellectual Property. We are waiting for the official text. However, it seemed better than many had predicted earlier this week. The U.S., while not blocking the resolution, noted it did not join the consensus on the text. Now attentions will turn to the WHO’s next move, which will be the July draft of the global strategy and plan of action.

Continue Reading

Uncategorized

Peter Pitts doesn’t like the KSR decision, or prizesP

Peter Pitts doesn’t like the KSR decision, and he also doesn’t like prizes. His recent Spectator article says:

DISTURBINGLY, SOME FOLKS ARE now advocating a “prize” system where there are no drug patents. Instead, the government would pay a drug maker a lump sum for its innovation, and then the new drug would immediately be placed in the public domain.

Continue Reading

Prize4Life

Prize4Life is an effort to accelerate treatments for Amyotrophic Lateral Sclerosis (ALS). It was created by 32 year old Avichai “Avi” Kremer. According to news reports Kremer was diagnosed with ALS in 2004, and has only a few years to live. He started Prize4Life to raise money for prizes to stimulation research.


Here are some extracts from this moving story in the March 28 issue of the Boston Globe:

Continue Reading

Uncategorized

March 8, 2007 Geneva Q&A Session on Thai White Paper

Knowledge Ecology International: Q&A Session on Thai White Paper (Facts and Evidences on the 10 Burning Issues Related to the Government Use of Patents on Three Patented Essential Drugs in Thailand) Geneva, Switzerland 8 March 2007 Thiru Balasubramaniam On Thursday,… Continue Reading

Christine LAGARDE asked to change EU “opt-out” of 30 August 2003 decision regarding imports of generic medicines manufactured under a compulsory license

Original page: http://www.cptech.org/ip/health/tamiflu/christinelagarde.html Christine LAGARDE asked to change EU “opt-out” of 30 August 2003 decision regarding imports of generic medicines manufactured under a compulsory license To: Christine LAGARDE, Ministre déléguée au Commerce extérieur, France From: Manon Ress and James Love,… Continue Reading

Senator Schumer Press release calling for use of 28 USC 1498 to authorize generic manufacture of oseltamivir (TN: Tamiflu)

Schumer’s October 16, 2005 press release As Avian Flu Closes In On U.S., Schumer Calls For Immediate Action: Demands Suspension Of Tamiflu Patent So Vaccine Can Be Mass-Produced, Dramatically Increasing Supply Tamiflu, the Only Effective Treatment of Bird Flu in… Continue Reading